Bieche We, Parfait B, Tozlu S, Lidereau R, Vidaud Yards: Quantitation away from androgen receptor gene term inside sporadic breast tumors of the real-big date RT-PCR: evidence one MYC is an AR-regulated gene. Carcinogenesis. 2001, twenty two (9): 1521-1526. /carcin/twenty two.9.1521.
Bratthauer GL, Lininger RA, Kid YG, Tavassoli FA: Androgen and you will the hormone estrogen receptor mRNA position within the apocrine carcinomas. Diagn Mol Pathol. 2002, 11 (2): 113-118. 9606-200206000-00008.
Gatalica Z: Immunohistochemical investigation out of apocrine nipple lesions. Uniform more than-expression of androgen receptor followed closely by losing the hormone estrogen and you may progesterone receptors within the apocrine metaplasia and apocrine carcinoma inside the situ. Pathol Res Pract. 1997, 193 (11-12): 753-758.
Am J Clin Pathol
Soreide JA, Lea OA, Varhaug JE, Skarstein An effective, Kvinnsland S: Androgen receptors for the operable cancer of the breast: regards to almost every other steroid hormone receptors, correlations so you’re able to prognostic items and you may predictive well worth to possess effectation of additive tamoxifen procedures. Eur J Surg Oncol. 1992, 18 (2): 112-118.
Bayer-Gather IB, Smoller B: Androgen receptors: a marker to increase susceptibility to have pinpointing breast cancer within the epidermis metastasis away from unknown pri, thirteen (2): 119-122. /modpathol.3880021.
Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic passion and you may scientific ramifications. J Clin Oncol. 2000, 18 (5): 1135-1149.
Pang ST, Flores-Morales A great, Skoog L, Chuan YC, Nordstedt G, Pousette An effective: Regulation of matrix metalloproteinase 13 phrase because of the androgen in the prostate cancer tumors. Oncol Rep. 2004, 11 (6): 1187-1192.
Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Cancer. 1984, 54 (11): 2436-2440. -0142(19841201)<2436::AID-CNCR2820541121>3.0.
Schippinger W, Regitnig P, Dandachi N, Wernecke KD, Bauernhofer T, Samonigg H, Moinfar F: Testing of your prognostic dependence on androgen receptor term inside the metastatic cancer of the breast. Virchows Arc. 2006, 449 (1): 24-31. /s00428-006-0213-six.
Parker RL, Hunter DG, Lesack DW, Cupples JB, Offer DR, Akbari Yards, Gilks CB: Comparison of interlaboratory adaptation in the immunohistochemical devotion from estrogen receptor position having fun with a breast cancer tissue microarray. 2002, 117 (5): 723-728. /PEF8-GL6F-YWMC-AG56.
Vizoso FJ, Gonzalez LO, Corte MD, Rodriguez JC, Vazquez J, Lamelas ML, , Garcia-Muniz JL: Examination of matrix metalloproteinases and their inhibitors for the breast cancer. Br J Cancer tumors. 2007, 96 (6): 903-911. /sj.bjc.6603666.
Narita D, Raica Yards, Suciu C, Cimpean A good, Anghel Good: Immunohistochemical phrase out-of androgen receptor and you can prostate-particular antigen in the cancer of the breast. Folia Histochem Cytobiol. 2006, 49 (3): 165-172.
Egeblad Yards, Werb Z: The fresh new attributes to the matrix metalloproteinases for the cancers progression. Nat Rev Cancer tumors. 2002, dos (3): 161-174. /nrc745.
Turk V, Kos J, Turk B: Cysteine cathepsins (proteases)–on fundamental stage away from cancer tumors?. Disease Cell. 2004, 5 (5): 409-410. /S1535-6108(04)00117-5.
Manes S, Llorente Meters, Lacalle RA, Gomez-Mouton C, Kremer L, Mira Age, Martinez Air cooling: The fresh new matrix metalloproteinase-nine regulates the fresh insulin-such as for example development grounds-brought about autocrine effect into the DU-145 carcinoma tissues. J Biol Chem. 1999, 274 (11): 6935-6945. /jbc..
Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel Meters: Release of an invasion supporter Age-cadherin fragment by matrilysin and you will stromelysin-step one. J Mobile Sci. 2001, 114 (Pt step one): 111-118.
Fingleton B, Vargo-Gogola T, Crawford HC, Matrisian LM: Matrilysin [MMP-7] expression picks for tissue with reduced awareness in order to apoptosis. Neoplasia. 2001, step three (6): 459-468. /sj.neo.7900190.
CO;2-H
Stetler-Stevenson WG: Matrix metalloproteinases in the angiogenesis: a relocation address to own healing intervention. J Clin Dedicate. 1999, 103 (9): 1237-1241. /JCI6870.
Cornelius La, Nehring LC, Harding Age, Bolanowski Yards, Welgus HG, Kobayashi DK, Pierce RA, Shapiro SD: Matrix metalloproteinases make angiostatin: consequences for the neovascularization. J Immunol. 1998, 161 (12): 6845-6852.
Jiang Y, Goldberg ID, Shi YE: Complex opportunities of tissues inhibitors away from metalloproteinases inside cancer tumors. Oncogene. 2002, 21 (14): 2245-2252. /sj.onc.1205291.